Tempol
- Generic Name
- Tempol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H18NO2
- CAS Number
- 2226-96-2
- Unique Ingredient Identifier
- U78ZX2F65X
- Background
Tempol has been used in trials studying the treatment of Anal Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
Phase 1
Terminated
- Conditions
- Anal Cancer
- Interventions
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 6
- Registration Number
- NCT01324141
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath